CANL Stock: CannLabs, Inc. Stock Price, Analysis & Insights
Get live CANL stock price $0.00, comprehensive CannLabs, Inc. stock analysis, charts, news, and expert forecast. Real-time CANL stock data and investment insights.
Loading chart data...
CannLabs, Inc. (CANL) Overview
CannLabs, Inc. (CANL) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, CANL trades at $0.00 with a market capitalization of 93.32K . Over the past 52 weeks, CANL has traded between $0.00 and $0.01 , with the current price positioned at approximately 0% of this range . The stock c...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 93.32K
- Current price: $0.00
- 52-week range: $0.00 - $0.01
- P/E ratio: 7.48
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Headquartered in Denver, Colorado, CannLabs, Inc. is a leading provider of cannabis testing laboratory services throughout the United States. The company offers an extensive suite of analytical tests, including assessments for potency, residual solve...
Company Information
- CEO
- Mark C. Mirken
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 37
Contact Information
- Website
- http://www.cannlabs.net
- Address
- 3888 East Mexico Avenue
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 5.59)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for CannLabs, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for CannLabs, Inc.
- ⚠Investors should consider how CannLabs, Inc. fits within their overall portfolio allocation
Market Cap
93.32K
Beta
5.59
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CANL with peer companies:
- Price
- $0.00
- Market cap
- 9.79K
- Price
- $0.00
- Market cap
- 98.41K
- Price
- $0.00
- Market cap
- 18.66K
- Price
- $0.17
- Market cap
- 156.00K
- Price
- $0.01
- Market cap
- 129.62K
- Price
- $0.00
- Market cap
- 70.18K
- Price
- $0.00
- Market cap
- 56.09K
- Price
- $0.00
- Market cap
- 29.56K
- Price
- $0.00
- Market cap
- 82.92K
- Price
- $0.01
- Market cap
- 39.18K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.